Suppression of bronchial response to platelet activating factor following taurine administration.
Research Center, Taisho Pharmaceutical Co., Ltd., Saitama, Japan.
M
M
Kurachi
K
K
Hongoh
A
A
Watanabe
H
H
Aihara
D000818:Animals; D001986:Bronchial Spasm / Q000503:physiopathology*; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D008168:Lung / Q000187:drug effects / Q000502:physiology* / Q000503:physiopathology; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D010974:Platelet Aggregation; D011738:Pyrilamine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013189:SRS-A / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology; D013654:Taurine / Q000494:pharmacology*
D010972:Platelet Activating Factor; D013189:SRS-A; D013654:Taurine; D012701:Serotonin; D011738:Pyrilamine; D007213:Indomethacin